|
Indian Pediatr 2013;50: 972-973 |
|
Should N-acetylcysteine be used in Treatment
of Non-acetaminophen Pediatric Acute Liver Failure?
|
Vikram Kumar
Department of Pediatrics, Fortis Memorial Research
Institute, Sector- 44,Gurgaon, Haryana, India.
Email: [email protected]
|
In a recently published consensus statement on management of acute liver
failure, the authors have recommended the use of N-acetylcysteine in the
treatment of children with non-acetaminophen pediatric acute liver
failure [1]. Intravenous N-acetyleysteine (NAC) was incorporated into
the general management of acute liver failure following a small
uncontrolled study suggesting improved cardiovascular hemodynamics and
oxygen transport in liver failure in adults [2]. In pediatric
population, NAC became popular after a retrospective single-center
review from Kortsalioudaki, et al. [3] which affirmed its
beneficial effect in acute liver failure. Based on these data, the
consensus among pediatric hepatologists over the years has been to use
this inexpensive medication in liver failure.
However, a recently published, decade long,
multi-centric, randomized placebo controlled study to test the
widespread assumption of usefulness of intravenous NAC in
non-acetaminophen pediatric liver failure by Squires, et al. [4]
does not support broad use of NAC in this condition. The study by
Squires, et al. in itself is unique with regard to its design and
the results and perhaps is the only prospective study in children which
tries to give an insight to the role of NAC in non- acetaminophen
pediatric liver failure. More prospective studies are still warranted
before we can establish the role of NAC in treatment of
non-acetaminophen pediatric acute liver failure.
References
1. Bhatia V, Bavdekar A, Yachha SK. Management of
acute liver failure in infants and children: Consensus Statement of the
Pediatric Gastroenterology Chapter, Indian Academy of Pediatrics. Indian
Pediatr. 2013;50;477-82.
2. Harrison PM, Wendon JA, Gimson AE, Alexander GJ,
Williams R. Improvement by acetylcysteine of hemodynamics and oxygen
transportin fulminant hepatic failure. N Engl J Med. 1991;324:1852-7.
3. Kortsalioudaki C, Taylor RM, Cheeseman P, Bansal
S, Mieli-Vergani G, Dhawan A. Safety and efficacy of N-acetylcysteine in
children with nonacetaminophen- induced acute liver failure. Liver
Transpl. 2008;14:25-30.
4. Squires RH, Dhawan A, Alonso E, Narkewicz MR,
Shneider BL, Rodriguez-Baez N, et al. Intravenous N-acetylcysteine
in pediatric patients with nonacetaminophen acute liver failure: A
placebo-controlled clinical trial. Hepatology. 2013;57:1542-9.
|
|
|
|